Recent Finacing
Recent Raise
Cognition Therapeutics develops small-molecule therapies and diagnostic assays for Alzheimer’s and other neurodegenerative diseases using disease-relevant screening and proprietary biology-chemistry platforms targeting soluble Abeta oligomer toxicity.
